NL-OMON39779已完成不适用
TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease. - ROW DNA test
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patient with Rendu Osler Weber disease who didn't have a mutation tested in the previous testmethod
- •Patients with known ENG or ALK mutation
排除标准
- •Patients without ROW
研究者
相似试验
已完成
不适用
ew approaches in genetic analysis to predict for CRC risk.Bowel CancerCancer - Bowel - AnalCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileumACTRN12605000259640CSIRO, Australia300
已完成
不适用
Research on genomic test utilizing next generation sequencer for solid tumors and development of the genome databaseJPRN-UMIN000028388iigata University995
招募中
不适用
Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models - the Lungmarker2 studylung carcinoma10029107lung cancerNL-OMON53764Catharina-ziekenhuis800
招募中
不适用
Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study)chromosomal aberriationsgenetic defect10083624NL-OMON37477eids Universitair Medisch Centrum300
已完成
不适用
Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)Metastatic Gastrointestinal CancerGenitourinary CancerNCT02140463Samsung Medical Center229